The Journal of Urology
Volume 179, Issue 1 , Pages 13-14 , January 2008

Low Risk Bladder Tumors—Less is More!

References 

  1. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466
  2. Montie JE, Abrahams NA, Bahnson RR, Eisenberger MA, El-Galley R, Herr HW, et al. Bladder cancer (Clinical guidelines in oncology). J Natl Compr Canc Netw. 2006;4:984
  3. Soloway MS. Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder. Urol Oncol. 2006;24:58
  4. Gofrit ON, Pode D, Lazar A, Katz R, Shapiro A. Watchful waiting policy in recurrent Ta G1 bladder tumors. Eur Urol. 2006;49:303
  5. Herr HW, Donat SM, Reuter VE. Management of low grade papillary bladder tumors. J Urol. 2007;178:1201
  6. Yossepowitch O, Herr HW, Donat SM. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. J Urol. 2007;177:1277
  7. Sylvester RJ, Oosterlinck W, van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol. 2004;171:2186
  8. Oddens JR, van der Meijden AP, Sylvester R. One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients (Is it always safe?). Eur Urol. 2004;46:336

PII: S0022-5347(07)02484-6

doi: 10.1016/j.juro.2007.09.014

The Journal of Urology
Volume 179, Issue 1 , Pages 13-14 , January 2008

Article Tools